N - [4-fluoro-5 - [[(2S, 4S) - 2-meth-4 - [(5-methyl-1,2,4-oxadiazol-3-il) methyl] - 1-piperidil] methyl] tiazol-2-il] acetate was used as an OGA inhibitor
LINDSAY-SCOTT, Peter James,DREYFUS, Nicolas Jacques Francois
申请号：
ECDI201953616
公开号：
ECSP19053616A
申请日:
2019.07.26
申请国别(地区):
EC
年份:
2019
代理人:
摘要：
The invention provides a compound of formula one or a formula salt that can be accepted by medicine, and uses a compound of formula one to treat diseases and neurodegenerative diseases, such as Alzheimer's disease.La presente invención proporciona un compuesto de Fórmula I o una sal farmacéuticamente aceptable del mismo, y el uso de compuestos de Fórmula I para el tratamiento de enfermedades y trastornos neurodegenerativos, tales como la enfermedad de Alzheimer.
